{"DataElement":{"publicId":"2431576","version":"1","preferredName":"Cutaneous Melanoma Negative Surgical Margin Closest Neoplasm Present NCI Concept Code","preferredDefinition":"Indicates the degree of invasiveness of neoplasm closest to the negative margin in a cutaneous melanoma specimen.","longName":"2431369v1.0:2433698v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431369","version":"1","preferredName":"Cutaneous Melanoma Negative Surgical Margin Closest Neoplasm","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.:definition pending_Indicating the one of several that is the shortest distance away.:An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic","longName":"2431289v1.0:2431215v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431289","version":"1","preferredName":"Cutaneous Melanoma Negative Surgical Margin","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.:definition pending","longName":"C3510:C48621","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma","conceptCode":"C3510","definition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Surgical Margin","conceptCode":"C48621","definition":"Indicates the absence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF3A5-2AED-3B6B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431215","version":"1","preferredName":"Closest Neoplasm","preferredDefinition":"Indicating the one of several that is the shortest distance away.:An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic","longName":"C25449:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Closest","conceptCode":"C25449","definition":"Indicating the one of several that is the shortest distance away.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE251-C145-3292-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE0684-CD5A-42C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2433698","version":"1","preferredName":"Cutaneous Melanoma Negative Surgical Margin Closest Neoplasm Present NCI Concept Code","preferredDefinition":"Indicates what neoplasm is closest to the margin._A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"2433698v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Invasive Melanoma","valueDescription":"Invasive Melanoma","ValueMeaning":{"publicId":"2577134","version":"1","preferredName":"Invasive Melanoma","longName":"2577134","preferredDefinition":"Invasive Melanoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Cutaneous Melanoma","conceptCode":"C48607","definition":"A melanoma of the skin that is not confined to the dermal-epidermal junction, and has infiltrated the dermis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA5B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"SBREXT","dateModified":"2005-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4D0-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Melanoma in Situ","valueDescription":"Stage 0 Skin Melanoma","ValueMeaning":{"publicId":"2580715","version":"1","preferredName":"Stage 0 Skin Melanoma","longName":"2580715","preferredDefinition":"A melanoma of the skin characterized by the presence of melanoma cells in the dermal-epidermal junction only, without infiltration of the papillary or reticular dermis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Cutaneous Melanoma AJCC v6 and v7","conceptCode":"C8423","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Melanoma in situ.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0858-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-08-31","modifiedBy":"CURTIST","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C537CC9-3C6A-5E1E-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-08-31","modifiedBy":"CURTIST","dateModified":"2006-08-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2183782","version":"1","preferredName":"NCIP","preferredDefinition":"Cancer Biomedical Informatics Grid","longName":"NCIP","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DACB2549-3BE3-73F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433292","version":"1","preferredName":"NCI Concept Code","preferredDefinition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"C43516","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCI Concept Code","conceptCode":"C43516","definition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"062A6784-EC8C-6CFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-22","modifiedBy":"ONEDATA","dateModified":"2005-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06459C26-C26D-6BA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CHILLIJ","dateModified":"2014-03-31","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley; added CAP CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2857187","version":"1","longName":"CAP Cancer Checklists","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812064","version":"1","longName":"edu.upmc.opi.cabig.caties.cap.domain.cutaneousMelanoma","context":"NCIP"}]}],"AlternateNames":[{"name":"CutaneousMelanomaNegativeSurgicalMargin:closestNeoplasmPresent","type":"UML Class:UML Attr","context":"NCIP"},{"name":"edu.upmc.opi.cabig.caties.cap.domain.cutaneousMelanoma.CutaneousMelanomaNegativeSurgicalMargin.closestNeoplasmPresent","type":"UML Qualified Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Specify neoplasm closest to m","type":"Preferred Question Text","description":"Specify neoplasm closest to margin","url":null,"context":"NCIP"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE6086-A7D6-5DA0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"CHILLIJ","dateModified":"2014-03-31","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}